scispace - formally typeset
Journal ArticleDOI

Charged particles in radiation oncology

Marco Durante, +1 more
- 01 Jan 2010 - 
- Vol. 7, Iss: 1, pp 37-43
Reads0
Chats0
TLDR
In this paper, a review of particle therapy in radiotherapy is presented, and the authors identify and discuss the research questions that have resulted with this technique, and conclude that the high costs of accelerators and beam delivery in particle therapy are justified by a clear clinical advantage.
Abstract
Radiotherapy is one of the most common and effective therapies for cancer. Generally, patients are treated with X-rays produced by electron accelerators. Many years ago, researchers proposed that high-energy charged particles could be used for this purpose, owing to their physical and radiobiological advantages compared with X-rays. Particle therapy is an emerging technique in radiotherapy. Protons and carbon ions have been used for treating many different solid cancers, and several new centers with large accelerators are under construction. Debate continues on the cost:benefit ratio of this technique, that is, on whether the high costs of accelerators and beam delivery in particle therapy are justified by a clear clinical advantage. This Review considers the present clinical results in the field, and identifies and discusses the research questions that have resulted with this technique.

read more

Citations
More filters
Journal ArticleDOI

Radiation oncology in the era of precision medicine

TL;DR: Two major strategies, acting synergistically, will enable further widening of the therapeutic window of radiation oncology in the era of precision medicine: technology-driven improvement of treatment conformity, including advanced image guidance and particle therapy, and novel biological concepts for personalized treatment.
Journal ArticleDOI

Chordoma: current concepts, management, and future directions

TL;DR: Treatment of clival chordomas is unique from other locations with an enhanced emphasis on preservation of neurological function, typified by a general paradigm of maximally safe cytoreductive surgery and advanced radiation delivery techniques.
Journal ArticleDOI

Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience.

TL;DR: A panel of radiation oncologists, radiobiologists, and medical physicists from the USA and Europe recently completed peer review of the carbon ion therapy at NIRS, and promising data were obtained for other tumours, such as locally recurrent rectal cancer and pancreatic cancer.
Journal ArticleDOI

Biological response of cancer cells to radiation treatment.

TL;DR: The clinical implications of radiation induced direct and bystander effects on the cancer cell are discussed and research and development in the last three decades has led to considerable improvement in understanding of the differential responses of normal and cancer cells.
Journal ArticleDOI

Physical basis and biological mechanisms of gold nanoparticle radiosensitization

TL;DR: There is an apparent disparity between the observed experimental findings and the level of radiosensitization predicted by mass energy absorption and GNP concentration, which is highlighted to highlight potential underlying biological mechanisms of response in GNP radiosensItization.
References
More filters
Journal ArticleDOI

Angiogenesis in cancer, vascular, rheumatoid and other disease

TL;DR: Think of the switch to the angiogenic phenotype as a net balance of positive and negative regulators of blood vessel growth, which may dictate whether a primary tumour grows rapidly or slowly and whether metastases grow at all.
Journal ArticleDOI

Association of reactive oxygen species levels and radioresistance in cancer stem cells

TL;DR: It is shown that normal mammary epithelial stem cells contain lower concentrations of ROS than their more mature progeny cells, and subsets of CSCs in some tumours contain lower ROS levels and enhanced ROS defences compared to their non-tumorigenic progeny, which may contribute to tumour radioresistance.
Journal ArticleDOI

Cancer risks attributable to low doses of ionizing radiation: Assessing what we really know

TL;DR: The difficulties involved in quantifying the risks of low-dose radiation are reviewed, a linear extrapolation of cancer risks from intermediate to very low doses currently appears to be the most appropriate methodology, and a linearity assumption is not necessarily the most conservative approach.
Journal ArticleDOI

Relative biological effectiveness (RBE) values for proton beam therapy.

TL;DR: There is too much uncertainty in the RBE value for any human tissue to propose RBE values specific for tissue, dose/fraction, proton energy, etc, and experimental in vivo and clinical data indicate that continued employment of a generic RBEvalue is reasonable.
Journal ArticleDOI

Intensity-modulated radiation therapy, protons, and the risk of second cancers.

TL;DR: Intensity-modulated radiation therapy (IMRT) allows dose to be concentrated in the tumor volume while sparing normal tissues, however, the downside to IMRT is the potential to increase the number of radiation-induced second cancers, so that doubling it may not be acceptable in older patients and in children.
Related Papers (5)